John Chalmers

languages spoken, written or signed: English

educated at: University of Sydney, University of New South Wales

occupation: medical researcher, physician, internist, physiologist

award received: Companion of the Order of Australia

John Philip Chalmers (born 12 January 1937) is an Australian medical researcher, best known for his work in the field of cardiovascular physiology, specifically for his research into hypertension.He is an Emeritus Professor of Medicine at both the University of Sydney and Flinders University in Adelaide and a professor of medicine at the University of New South Wales in Sydney. Chalmers is also a senior director at the George Institute for Global Health. Source: Wikipedia (en)

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 381

Date

Title

Authors

2022-10-25

Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis

Htein Linn Aung, Jessica Gong, Ying Xu, Peter Humburg, Ruth Peters, Craig S. Anderson, Christophe Tzourio, John Chalmers, Fiona E. Matthews, Lutgarde Thijs
2020-03-19

The Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE Trial

Jingyan Tian, Toshiaki Ohkuma, Sophia Zoungas, John Chalmers, Neil R Poulter, Stephen Harrap
2020-01-22

Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm

Xiaoying Chen, Jingwei Li, Craig S. Anderson, Maree L. Hackett, Thompson Robinson, Xia Wang, John Chalmers, Pablo M. Lavados, Richard I Lindley, ENCHANTED Investigators, Hisatomi Arima, Candice Delcourt
2019-11-12

Sex differences in treatment and outcome after stroke: Pooled analysis including 19,000 participants

Cheryl Carcel, Candice Delcourt, Richard I Lindley, Thompson Robinson, John Chalmers
2019-12-11

Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis

Ruth Peters, Shea Andrews, Joanne C Beer, John Chalmers, Carol Jagger, Patrick G. Kehoe, Sirkka Keinänen-Kiukaanniemi, Sebastian Köhler, Tze Pin Ng, Iris Rawtaer, Lina Rydén, Johan Skoog, Jan A. Staessen, Phillip J Tully, Christophe Tzourio, Kaarin J. Anstey, Steven T. DeKosky, Kenneth Rockwood, Stella Trompet, Jari A. Laukkanen, Edo Richard, Maria M Corrada, Setor K Kunutsor, Willem A van Gool, Rose Anne Kenny, Carol Brayne, Andrew Booth, Lutgarde Thijs, Nigel S Beckett
2019-06-03

Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes

John Chalmers, Pavel Hamet
2019-06-21

Who will benefit more from low-dose alteplase in acute ischemic stroke?

Xia Wang, Tom J Moullaali, Cheryl Carcel, Candice Delcourt, Thompson Robinson, Lili Song, John Chalmers, Richard I Lindley, Craig S. Anderson, Keon Joo Lee, Hee-Joon Bae, Shoichiro Sato, ENCHANTED Investigators, Hisatomi Arima
2019-04-08

Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry

Thompson Robinson, Lizz Paley, Xia Wang, Philip M W Bath, Sheila Martins, Vijay K Sharma, John Chalmers, Craig S. Anderson, Pablo M. Lavados, Octavio M Pontes-Neto, Tsong-Hai Lee, Hisatomi Arima, Joseph P. Broderick, Jeyaraj Pandian, Nikola Sprigg, Jiguang Wang
2018-03-01

Response to Comment on Ohkuma et al. Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial. Diabetes Care 2017;40:1203-1209

Toshiaki Ohkuma, John Chalmers
2018-03-20

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data.

Paul P. Glasziou, Anthony Rodgers, Kazem Rahimi, Johan Sundström, Joep van der Leeuw, David C Goff, Salim Yusuf, Bruce Neal, Koon Teo, John Chalmers, Carl J Pepine, Donald Lloyd-Jones, Barry R. Davis
2017-08-01

Frequency, determinants, and effects of early seizures after thrombolysis for acute ischemic stroke: The ENCHANTED trial.

Xia Wang, Thompson Robinson, Maree L. Hackett, Craig S. Anderson, John Chalmers, Ying Xu, Pablo M. Lavados, Richard I Lindley, Hisatomi Arima
2017-10-27

Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON

Min Jun, Toshiaki Ohkuma, Sophia Zoungas, Stephen Colagiuri, Anthony Rodgers, John Chalmers, Neil R Poulter, ADVANCE-ON Collaborative Group, Vlado Perkovic, Michel Marre
2017-08-01

Guidelines under fire again!

John Chalmers
2017-01-27

eHealth Literacy: Predictors in a Population With Moderate-to-High Cardiovascular Risk

Sarah S Richtering, Karice Hyun, Lis Neubeck, Genevieve Coorey, John Chalmers, Tim Usherwood, David Peiris, Clara Chow, Julie Redfern
2017-03-08

Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene

Pavel Hamet, Johanne Tremblay, John Chalmers
2017-01-05

PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study

Pavel Hamet, Johanne Tremblay, John Chalmers
2017-02-24

Intracerebral hemorrhage location and outcome among INTERACT2 participants

Maree L. Hackett, Christian Stapf, Thompson Robinson, Richard I Lindley, Craig S. Anderson, John Chalmers, Rustam Al-Shahi Salman, Charlotte Cordonnier, Emma Heeley, Jun Hata, Pablo M. Lavados, Hisatomi Arima, Candice Delcourt, Shoichiro Sato, Else Charlotte Sandset, INTERACT2 Investigators
2017-07-24

Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis

Susan Carr, Xia Wang, Richard I Lindley, Vijay K Sharma, John Chalmers, Craig S. Anderson, Thompson Robinson, Pablo M. Lavados, Octavio M Pontes-Neto, Shoichiro Sato, Tsong-Hai Lee, Verónica V Olavarría, ENCHANTED Investigators
2017-06-15

Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).

Andrew M Demchuk, Xia Wang, Laurent Billot, Vijay K Sharma, Thompson Robinson, Richard I Lindley, Craig S. Anderson, John Chalmers, Pablo M. Lavados, Octavio M Pontes-Neto, Shoichiro Sato, Tsong-Hai Lee, Verónica V Olavarría, ENCHANTED Investigators, Hisatomi Arima, Philip M W Bath, Joseph P. Broderick, Sheila Martins, Jeyaraj Pandian
2017-06-05

Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study

Min Jun, Stephen Colagiuri, John Chalmers, Giuseppe Mancia, Peter M. Rothwell, Paul Muntner, Jun Hata, Neil R Poulter, ADVANCE-ON Collaborative Group, Stephen Harrap
2017-06-05

Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Ruth Webster, Bruce Neal, David Peiris, John Chalmers, Sarah Hilmer, Anthony Rodgers, Anushka Patel, Graham S Hillis, Clara Chow, Hakim-Moulay Dehbi, Jay Thakkar, Tim Usherwood
2017-05-17

Dietary salt intake in the Australian population

Jacqui Webster, John Chalmers, Bruce Neal, Kristina S Petersen, Victoria M Flood, Mary-Anne Land
2017-05-01

Cumulative in-trial and post-trial effects of blood pressure and lipid lowering: systematic review and meta-analysis

Anthony Rodgers, John Chalmers
2017-02-09

Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review

Ruth Webster, Bruce Neal, David Peiris, John Chalmers, Sarah Hilmer, Anthony Rodgers, Anushka Patel, Graham S Hillis, Clara Chow, Hakim-Moulay Dehbi, Jay Thakkar, Tim Usherwood
2017-03-01

Withdrawal of active treatment after intracerebral haemorrhage in the INTERACT2 study

Paula Muñoz Venturelli, Xia Wang, Christian Stapf, Richard I Lindley, Candice Delcourt, John Chalmers, Craig S. Anderson, Thompson Robinson, Pablo M. Lavados, INTERACT2 Investigators
2017-02-23

Using administrative data to look at changes in the level and distribution of out-of-pocket medical expenditure: An example using Medicare data from Australia

Xinyang Hua, Guido Erreygers, John Chalmers, Tracey-Lea Laba
2017-04-27

Examination of an eHealth literacy scale and a health literacy scale in a population with moderate to high cardiovascular risk: Rasch analyses

David Peiris, John Chalmers, Lis Neubeck, Clara Chow
2017-03-29

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials

Sophia Zoungas, Hertzel C. Gerstein, Rury Holman, John Chalmers, Hisatomi Arima, Peter D Reaven, Ruth L Coleman
2017-10-10

Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk.

Dennis Petrie, Rod Jackson, Josh Knight, Duncan Mortimer, John Chalmers
2017-06-26

Guidelines Under Fire Again!

John Chalmers
2017-06-01

Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials.

Pavel Hamet, John Chalmers, Giuseppe Mancia, Neil R Poulter, Yoichiro Hirakawa, Anthony Rodgers, Stephen Harrap, Vlado Perkovic, Michel Marre, Kennedy R. Lees
2017-08-01

Microvascular outcomes in type 2 diabetes - Authors' reply

Sophia Zoungas, Hertzel C. Gerstein, Rury Holman, John Chalmers, Hisatomi Arima, Peter D Reaven, Ruth L Coleman

Human - wd:Q54269945

Welcome to Inventaire

the library of your friends and communities

learn more